Radius Health (NASDAQ:RDUS) reported Q1 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $43 million versus the consensus estimate of $51.28 million.
GUIDANCE:
Radius Health sees FY2022 revenue of $232 million.